pimagedine has been researched along with transforming growth factor beta in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adashi, EY; Ben-Shlomo, I; Payne, DW | 1 |
| Cooper, ME; Cox, A; Gilbert, RE; Jasik, M; Jerums, G; Rumble, JR; Soulis, T; Wu, L; Youssef, S | 1 |
| Cresci, B; Di Mario, U; Galli, G; Giannini, S; Mené, P; Pricci, F; Pugliese, F; Pugliese, G; Romeo, G; Rotella, CM; Vlassara, H | 1 |
| Huang, CC; Ko, YC; Yang, CW; Yu, CC | 1 |
| Bone-Larson, C; Chensue, SW; Gallinat, CS; Hogaboam, CM; Kunkel, SL; Lukacs, NW; Strieter, RM | 1 |
| Baranda, P; Blasco, MR; Castejón, R; García-Merino, A; Martínez, I; Puerta, C; Vargas, JA | 1 |
| Cooper, ME; Cox, AJ; Gilbert, RE; Jerums, G; Kelly, DJ; Soulis, T | 1 |
| Benedetti, R; Benencia, F; Bonorino, P; Cavalieri, H; Courreges, MC; Gamba, G; Gonzalez-Videla, R; Massouh, EJ | 1 |
| Akalin, S; Burçak, G; Cetinel, S; Civelek, S; Deyneli, O; Haklar, G; Kaya, H; San, T; Tuğtepe, H; Uyar, S; Yavuz, D | 1 |
| Dy, V; Gilbert, RE; Kelly, DJ; Langham, RG; McLennan, SV; Schache, M; Waltham, M; Yue, DK | 1 |
| Chen, L; Chen, YJ; Li, JQ; Liu, DS; Liu, L; Sun, BB; Wang, T; Wang, X; Wen, FQ; Xu, D; Zhang, SF | 1 |
| Bolton, WK; Turgut, F | 1 |
1 review(s) available for pimagedine and transforming growth factor beta
| Article | Year |
|---|---|
Potential new therapeutic agents for diabetic kidney disease.
Topics: Amides; Animals; Clinical Trials as Topic; Connective Tissue Growth Factor; Diabetic Nephropathies; Disease Progression; Endothelin Receptor Antagonists; Glycation End Products, Advanced; Glycosaminoglycans; Guanidines; Humans; Hydrazines; Kidney; NADPH Oxidases; Nitric Oxide Synthase; Pentoxifylline; Phosphodiesterase Inhibitors; Pyridines; Pyridoxamine; Pyrimidines; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vitamin B Complex | 2010 |
11 other study(ies) available for pimagedine and transforming growth factor beta
| Article | Year |
|---|---|
The morphogenic/cytotoxic and prostaglandin-stimulating activities of interleukin-1 beta in the rat ovary are nitric oxide independent.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cells, Cultured; Dinoprostone; Female; Guanidines; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; L-Lactate Dehydrogenase; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Nitroprusside; omega-N-Methylarginine; Ovary; Rats; Rats, Sprague-Dawley; Sialoglycoproteins; Transforming Growth Factor beta | 1994 |
Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products.
Topics: Animals; Blotting, Northern; Body Weight; Collagen; Diabetes Mellitus, Experimental; DNA Probes; Extracellular Matrix; Gene Expression Regulation; Glucose; Glycation End Products, Advanced; Guanidines; Hypertrophy; Immunohistochemistry; In Situ Hybridization; Male; Mesenteric Arteries; Radioimmunoassay; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta | 1997 |
Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
Topics: Animals; Cattle; Cell Division; Cells, Cultured; Collagen; Extracellular Matrix; Extracellular Matrix Proteins; Fibronectins; Gene Expression Regulation; Glomerular Mesangium; Glycation End Products, Advanced; Guanidines; Humans; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Kinetics; Laminin; Rats; Receptor for Advanced Glycation End Products; Receptor, IGF Type 1; Receptor, IGF Type 2; Receptors, Immunologic; RNA, Messenger; Serum Albumin; Serum Albumin, Bovine; Transcription, Genetic; Transforming Growth Factor beta; Up-Regulation | 1997 |
Aminoguanidine reduces glomerular inducible nitric oxide synthase (iNOS) and transforming growth factor-beta 1 (TGF-beta1) mRNA expression and diminishes glomerulosclerosis in NZB/W F1 mice.
Topics: Animals; Body Weight; Cell Count; Creatine; Crosses, Genetic; Enzyme Inhibitors; Female; Guanidines; Hypertrophy; Kidney Glomerulus; Lupus Nephritis; Male; Mice; Mice, Inbred NZB; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Organ Size; Proteinuria; RNA, Messenger; Transforming Growth Factor beta | 1998 |
Collagen deposition in a non-fibrotic lung granuloma model after nitric oxide inhibition.
Topics: Animals; Cells, Cultured; Chemokine CCL11; Chemokine CCL2; Chemokine CCL3; Chemokine CCL4; Chemokines, CC; Collagen; Cytokines; Enzyme Inhibitors; Female; Fibroblasts; Granuloma, Respiratory Tract; Guanidines; Interferon-gamma; Interleukins; Lung Diseases; Macrophage Inflammatory Proteins; Mice; Mice, Inbred CBA; NG-Nitroarginine Methyl Ester; Nitric Oxide; Procollagen; Receptors, CCR2; Receptors, CCR3; Receptors, Chemokine; Specific Pathogen-Free Organisms; Transforming Growth Factor beta; Tuberculin | 1998 |
Aminoguanidine reduces apoptosis of circulating V Beta 8.2 T lymphocytes in Lewis rats with actively induced experimental autoimmune encephalomyelitis. Association with persistent inflammation of the central nervous system and lack of recovery.
Topics: Animals; Apoptosis; Cell Division; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Gene Expression; Guanidines; Guinea Pigs; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-10; Myelin Basic Protein; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Rats; Rats, Inbred Lew; Receptors, Antigen, T-Cell, alpha-beta; Recovery of Function; Spinal Cord; T-Lymphocytes; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2000 |
Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.
Topics: Animals; Autoradiography; Collagen; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression; Glomerulosclerosis, Focal Segmental; Glycation End Products, Advanced; Growth Substances; Guanidines; Immunohistochemistry; In Situ Hybridization; Kidney Glomerulus; Kidney Tubules; Male; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
Nitric oxide modulation of the immune response against cholera toxin-adjuvated ovalbumin administered by the intranasal route.
Topics: Administration, Intranasal; Animals; Cholera Toxin; Guanidines; Immunity, Cellular; Immunity, Mucosal; Lung; Mice; Nitric Oxide; Nitric Oxide Synthase; Ovalbumin; Transforming Growth Factor beta; Turbinates | 2004 |
Collagen ultrastructure and TGF-beta1 expression preserved with aminoguanidine during wound healing in diabetic rats.
Topics: Animals; Collagen; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Epithelium; Extracellular Matrix Proteins; Fibroblasts; Gene Expression; Glycation End Products, Advanced; Guanidines; Immunohistochemistry; Lipid Peroxidation; Male; Microscopy, Electron; Nitrates; Nitric Oxide; Nitrites; Oxidative Stress; Rats; Rats, Wistar; Skin; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta; Transforming Growth Factor beta1; Wound Healing; Wounds and Injuries | 2005 |
Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy?
Topics: Adult; Animals; Antibodies; Cells, Cultured; Culture Media, Conditioned; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Down-Regulation; Female; Fibronectins; Glycation End Products, Advanced; Glycosylation; Guanidines; Humans; Male; Matrix Metalloproteinase 10; Matrix Metalloproteinase 3; Matrix Metalloproteinase 7; Mesangial Cells; Middle Aged; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors; Transforming Growth Factor beta | 2007 |
Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats.
Topics: Animals; Antimetabolites, Antineoplastic; Bleomycin; Blotting, Western; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Guanidines; HSP47 Heat-Shock Proteins; Hydroxyproline; Lung; Male; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta | 2009 |